SCHEMBL23637708

SCHEMBL23637708

COC(=O)NC(C)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21150125 0.79 SMN1; SMN2 (0.35)
SCHEMBL21149285 0.79 SMN1; SMN2 (0.35)
SCHEMBL9665646 0.77 TDP1 (0.39)
SCHEMBL1106979 0.77
SCHEMBL15478609 0.74
SCHEMBL3641120 0.74
SCHEMBL8141423 0.72 SMN1; SMN2 (0.39)
SCHEMBL16266424 0.72
SCHEMBL18117417 0.72
SCHEMBL10125333 0.72 SMN1; SMN2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192728-A1 MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS, METHODS OF MAKING, AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY (US) 2023-06-22 US disclosed
US-20210214378-A1 MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS, METHODS OF MAKING, AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY (US) 2021-07-15 US disclosed